1. |
Smelter E, Hochberg MC. New treatments for osteoarthritis. Curr Opin Rheumatol, 2013, 25(3): 310-316.
|
2. |
Tang X, Wang S, Zhan S, et al. The prevalence of symptomatic knee osteoarthritis in China: results from the china health and retirement longitudinal study. Arthritis Rheumatol, 2016, 68(3): 648-653.
|
3. |
Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum, 2008, 58(1): 26-35.
|
4. |
Liu Q, Niu J, Huang J, et al. Knee osteoarthritis and all-cause mortality: the Wuchuan Osteoarthritis Study. Osteoarthritis Cartilage, 2015, 23(7): 1154-1157.
|
5. |
Xing D, Xu Y, Liu Q, et al. Osteoarthritis and all-cause mortality in worldwide populations: grading the evidence from a meta-analysis. Sci Rep, 2016, 6: 24393.
|
6. |
Conaghan PG, Dickson J, Grant RL, et al. Care and management of osteoarthritis in adults: summary of NICE guidance. BMJ, 2008, 336(7642): 502-503.
|
7. |
Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken), 2012, 64(4): 465-474.
|
8. |
Jevsevar DS, Brown GA, Jones DL, et al. The American Academy of Orthopaedic Surgeons evidence-based guideline on: treatment of osteoarthritis of the knee, 2nd edition. J Bone Joint Surg Am, 2013, 95(20): 1885-1886.
|
9. |
Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis, 2003, 62(12): 1145-1155.
|
10. |
Zhang W, Nuki G, Moskowitz RW, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage, 2010, 18(4): 476-499.
|
11. |
Feuerstein JD, Pelsis JR, Lloyd S, et al. Systematic analysis of the quality of the scientific evidence and conflicts of interest in osteoarthritis of the hip and knee practice guidelines. Semin Arthritis Rheum, 2016, 45(4): 379-385.
|
12. |
Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 2008, 336(7650): 924-926.
|
13. |
Institute of Medicine. Clinical Practice Guidelines We Can Trust. Washington. DC: The National Academies Press, 2011.
|
14. |
Brouwers MC, Kerkvliet K, Spithoff K, et al. The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ, 2016, 352: i1152.
|
15. |
Sinclair D, Isba R, Kredo T, et al. World Health Organization guideline development: an evaluation. PLoS One, 2013, 8(5): e63715.
|
16. |
杨克虎, 主译. 世界卫生组织指南制定手册, 兰州: 兰州大学出版社, 2013.
|
17. |
Alonso-Coello P, Oxman AD, Moberg J, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. BMJ. 2016, 353: i2089.
|
18. |
Chen Y, Yang K, Marusic A, et al. A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement. Ann Intern Med, 2017, 166(2): 128-132.
|